Related Experiment Videos
Lymphatic mapping and sentinel lymph node biopsy for breast cancer
Douglas Reintgen1, Rosemary Giuliano, Charles Cox
1Comprehensive Breast Cancer Program, Lakeland Regional Cancer Center, FL 33804-1057, USA.
Cancer Journal (Sudbury, Mass.)
|June 22, 2002
Summary
Lymphatic mapping improves melanoma and breast cancer staging accuracy, reducing patient morbidity. This technique enhances disease staging for approximately 10% of patients initially classified as histologic negative.
Area of Science:
- Oncology
- Surgical Pathology
- Medical Imaging
Background:
- Lymphatic mapping and sentinel lymph node biopsy are revolutionizing cancer care.
- These techniques offer improved disease staging and reduced patient morbidity.
- Standardization of these methods is progressing nationwide.
Purpose of the Study:
- To highlight the impact of lymphatic mapping on melanoma and breast cancer surgical care.
- To underscore the potential for more accurate disease staging and reduced morbidity.
- To discuss the ongoing standardization and national trials for lymphatic mapping.
Main Methods:
- Preoperative lymphoscintigraphy.
- Intraoperative lymphatic mapping techniques.
- Standardization of mapping procedures across healthcare facilities.
Main Results:
- Lymphatic mapping enhances the accuracy of disease staging in melanoma and breast cancer patients.
- The technique leads to a significant reduction in patient morbidity.
- Approximately 10% of histologically negative cases are more accurately staged using this method.
Conclusions:
- Lymphatic mapping and sentinel lymph node biopsy represent a significant advancement in cancer surgical care.
- Accurate staging and reduced morbidity are key benefits of these techniques.
- Ongoing national trials aim to further define the clinical significance of micrometastatic disease detection.